keytruda
-
Medical Research
Groundbreaking Advancements in Ovarian Cancer Treatment: Keytruda and Lifyorli Offer New Hope for Platinum-Resistant Disease
In a significant stride for oncology, two distinct pharmaceutical agents, Keytruda (pembrolizumab) from Merck & Co. (known as MSD outside…
Read More »